Clinical Trial
. 1991 Dec;14(2):183-4; discussion 185-6.
Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial
Affiliations
- PMID: 1812431
Item in Clipboard
Clinical Trial
Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial
NIPH Ann.
1991 Dec.
No abstract available
Similar articles
-
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.NIPH Ann. 1991 Dec;14(2):147-55; discussion 155-6. NIPH Ann. 1991. PMID: 1812429
-
Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.NIPH Ann. 1991 Dec;14(2):211-2; discussion 213. NIPH Ann. 1991. PMID: 1812433 Clinical Trial. No abstract available.
-
Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies.NIPH Ann. 1991 Dec;14(2):169-79; discussion 180-1. NIPH Ann. 1991. PMID: 1687481
-
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
-
Development of a meningococcal vaccine.Infect Agents Dis. 1995 Mar;4(1):13-28. Infect Agents Dis. 1995. PMID: 7728353 Review. No abstract available.
Cited by
-
Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.Infect Immun. 1998 Jul;66(7):3223-31. doi: 10.1128/IAI.66.7.3223-3231.1998. Infect Immun. 1998. PMID: 9632589 Free PMC article.
-
Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.Infect Immun. 1999 May;67(5):2552-60. doi: 10.1128/IAI.67.5.2552-2560.1999. Infect Immun. 1999. PMID: 10225920 Free PMC article.
-
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.Infect Immun. 1995 Dec;63(12):4642-52. doi: 10.1128/iai.63.12.4642-4652.1995. Infect Immun. 1995. PMID: 7591118 Free PMC article. Clinical Trial.
-
Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.Infect Immun. 2003 Jul;71(7):3775-81. doi: 10.1128/IAI.71.7.3775-3781.2003. Infect Immun. 2003. PMID: 12819059 Free PMC article.
-
Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway.Clin Diagn Lab Immunol. 1995 May;2(3):314-21. doi: 10.1128/cdli.2.3.314-321.1995. Clin Diagn Lab Immunol. 1995. PMID: 7664178 Free PMC article.